Related references
Note: Only part of the references are listed.ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Hao Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer
Chuan-yi Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra et al.
FRONTIERS IN ONCOLOGY (2020)
RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C-dependent manner
Lin Mei et al.
CELL DEATH & DISEASE (2020)
m6A-dependent glycolysis enhances colorectal cancer progression
Chaoqin Shen et al.
MOLECULAR CANCER (2020)
Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
Chara Papadaki et al.
CANCERS (2020)
PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
Tian-En Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients
Hai Hu et al.
JOURNAL OF CANCER (2020)
Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis
Ting Tao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Genome-wide identification of mRNA 5-methylcytosine in mammals
Tao Huang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
Jie Han et al.
MOLECULAR CANCER (2019)
5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
Xin Chen et al.
NATURE CELL BIOLOGY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
Maosheng Cheng et al.
ONCOGENE (2019)
MODOMICS: a database of RNA modification pathways. 2017 update
Pietro Boccaletto et al.
NUCLEIC ACIDS RESEARCH (2018)
JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
Aziz Khan et al.
NUCLEIC ACIDS RESEARCH (2018)
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Mami Morita et al.
CANCER CELL (2018)
LncRNA-FEZFl-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling
Zehua Bian et al.
CLINICAL CANCER RESEARCH (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway
Qiang Zhu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Human C-to-U Coding RNA Editing Is Largely Nonadaptive
Zhen Liu et al.
MOLECULAR BIOLOGY AND EVOLUTION (2018)
Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
Chengdi Yang et al.
MOLECULAR CANCER (2018)
RNA-modifying proteins as anticancer drug targets
P. Ann Boriack-Sjodin et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis
Changkun Huang et al.
ONCOTARGETS AND THERAPY (2018)
The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells
Robert Kleszcz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Yonggang Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer
Man Guo et al.
ONCOTARGET (2017)
Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
Xing Wang et al.
SCIENTIFIC REPORTS (2017)
5-methylcytosine promotes mRNA export-NSUN2 as the methyltransferase and ALYREF as an m5C reader
Xin Yang et al.
CELL RESEARCH (2017)
Metabolic phenotype of bladder cancer
Francesco Massari et al.
CANCER TREATMENT REVIEWS (2016)
PKM2, cancer metabolism, and the road ahead
Talya L. Dayton et al.
EMBO REPORTS (2016)
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
Talya L. Dayton et al.
GENES & DEVELOPMENT (2016)
PKM2 and cancer: The function of PKM2 beyond glycolysis
Gaochao Dong et al.
ONCOLOGY LETTERS (2016)
Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
Eva M. Palsson-McDermott et al.
CELL METABOLISM (2015)
Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
Q. Xu et al.
ONCOGENE (2015)
A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis
Xiao Yang et al.
TUMOR BIOLOGY (2015)
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Kate D. Meyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
ALY as a potential contributor to metastasis in human oral squamous cell carcinoma
Yasuhiro Saito et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA
Jeffrey E. Squires et al.
NUCLEIC ACIDS RESEARCH (2012)
hnRNP C Tetramer Measures RNA Length to Classify RNA Polymerase II Transcripts for Export
Asako McCloskey et al.
SCIENCE (2012)
Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers
Maria S. Dominguez-Sanchez et al.
BMC CANCER (2011)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang et al.
NATURE (2011)
RNA cytosine methylation analysis by bisulfite sequencing
Matthias Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Bringing order to translation: the contributions of transfer RNA anticodon-domain modifications
Paul F. Agris
EMBO REPORTS (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Gregg L. Semenza
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Post-transcriptional nucleotide modification and alternative folding of RNA
M Helm
NUCLEIC ACIDS RESEARCH (2006)
Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors
IF Robey et al.
NEOPLASIA (2005)
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
HS Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
PROMO:: detection of known transcription regulatory elements using species-tailored searches
X Messeguer et al.
BIOINFORMATICS (2002)
Share Paper
